FACULTY AFFILIATIONS

Joanne L Blum, MD, PhD
Director, Hereditary Cancer Risk Program and Research Site Leader
Baylor-Charles A Sammons Cancer Center
Dallas, Texas

Lesley Fallowfield, PhD
Professor of Psycho Oncology
University of Sussex, School of Biological Sciences
Brighton, United Kingdom

Kathy D Miller, MD
Sheila D Ward Scholar of Medicine
Assistant Professor of Medicine Department of Hematology/Oncology
Indiana University School of Medicine
Indianapolis, Indiana

Anita Rush-Taylor, RN, CCRC
Breast Oncology Research Nurse Coordinator
Breast Care and Research Center
Indiana University Cancer Center
Indianapolis, Indiana

Barbara Thompson, RN
Clinical Coordinator
Breast Care and Research Team
Indiana University School of Medicine
Indianapolis, Indiana

DISCLOSURES

Postgraduate Institute for Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. The presenting faculty reported the following:

Dr Blum – Speakers Bureau: American BioScience Inc, AstraZeneca Pharmaceuticals LP, Myriad Genetics Inc, Roche Laboratories Inc, Sanofi-Aventis. Dr Fallowfield – Grants/Research Support and Consultant: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals, Ortho Biotech Products LP, Pfizer Inc; Honorarium: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Ortho Biotech Products LP, Pfizer Inc; Speakers Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Novartis Pharmaceuticals, Ortho Biotech Products LP, Pfizer Inc. Dr Miller – Grants/ Research Support: GlaxoSmithKline, Medarex Inc, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis. Nurse Rush-Taylor – No financial affiliations or interests to disclose. Nurse Thompson – Speakers Bureau: Genomic Health Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Postgraduate Institute for Medicine (PIM), Research To Practice, Abraxis Oncology, AstraZeneca Pharmaceuticals LP and Roche Laboratories Inc do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Research To Practice, Abraxis Oncology, AstraZeneca Pharmaceuticals LP and Roche Laboratories Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.